Participate in a Prostate Cancer Focus Group Study and Earn $275
ZERO and Us TOO are working directly with IQVIA to recruit PATIENTS & CAREGIVERS who have had their, or their partners PSA double within one year after treatment. Please read the below for more details if you qualify and to fill out the screener provided by IQVIA.
IQVIA (www.iqvia.com), a healthcare research firm, is currently conducting a focus group study with patients who have experienced a doubling of their Prostate Specific Antigen (PSA) level within a year of being treated for prostate cancer (sometimes his is also called biochemically recurrent prostate cancer).
The video focus groups will last approximately 2.5 hours. If you are eligible, you will also be asked to complete a form which confirms your diagnosis and a brief online survey about your symptoms. In appreciation of your time, after the focus group, you will receive a $275 electronic gift card.
This research will focus on gaining an understanding of your experience with biochemically recurrent prostate cancer. This research may help improve our overall understanding of the patient and caregiver experience in high risk biochemically recurrent prostate cancer. The focus groups will be scheduled to take place the next several weeks of 2023.
The study is strictly for scientific research purposes; there will be absolutely no sales or promotional activities.
If you are interested, please click on this link to fill out the screener. https://survey.cmix.
Please email firstname.lastname@example.org if you have any problems with the form or questions.